drugset / Trial / NCT00164151

A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.

NCT00164151

Phase 3 Completed 60 enrolled Braintree Laboratories
RandomizedFactorialSingle-blind

Summary

The objective of this study is to determine the efficacy and safety of HalfLytely as compared to Visicol as bowel preparations before colonoscopic examination.

Timeline

Start
2001-06
Primary completion
2002-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Bisacodyl Small molecule 20 mg
Subject NuLYTELY Unknown 2000 ml
Subject Visicol Unknown

Indications

No indication recorded.